Recent comprehensive genomic analyses of two chRCC cohorts demonstrated a low exonic somatic mutation rate in these tumours and identified TP53 (20–32%) and PTEN (6–9%) as the most frequently mutated genes [16,17]. This evidence concerns the gene TP53 and neoplasm.